Cargando…

Association of anthropometric measures with kidney disease progression and mortality: a retrospective cohort study of pre-dialysis chronic kidney disease patients referred to a specialist renal service

BACKGROUND: Although elevated body mass index (BMI) is a predictor of better clinical outcomes in dialysis patients, the evidence in pre-dialysis chronic kidney disease (CKD) is conflicting. Clinical measures of central obesity may be better prognostic indicators, although investigation has been lim...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Emma, Campbell, Katrina, Gobe, Glenda, Hawley, Carmel, Isbel, Nicole, Johnson, David W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939033/
https://www.ncbi.nlm.nih.gov/pubmed/27391644
http://dx.doi.org/10.1186/s12882-016-0290-y
_version_ 1782441950846124032
author Davis, Emma
Campbell, Katrina
Gobe, Glenda
Hawley, Carmel
Isbel, Nicole
Johnson, David W.
author_facet Davis, Emma
Campbell, Katrina
Gobe, Glenda
Hawley, Carmel
Isbel, Nicole
Johnson, David W.
author_sort Davis, Emma
collection PubMed
description BACKGROUND: Although elevated body mass index (BMI) is a predictor of better clinical outcomes in dialysis patients, the evidence in pre-dialysis chronic kidney disease (CKD) is conflicting. Clinical measures of central obesity may be better prognostic indicators, although investigation has been limited. The aim of this study was to assess the predictive value of anthropometric measures for kidney failure progression and mortality in stage 3–4 CKD. METHODS: The study included newly referred stage 3–4 CKD patients at a single centre between 1/1/2008 and 31/12/2010. The associations between clinical measures of obesity (BMI, waist circumference [WC] and conicity index [ConI]) and time to a composite primary outcome of doubling of serum creatinine, commencement of renal replacement therapy or mortality were evaluated using the Kaplan-Meier method and multivariable Cox regression models. RESULTS: Over a median follow-up period of 3.3 years, 229 (25.4 %) patients of a total population of 903 experienced the composite primary renal outcome. When compared to normal BMI (18.5-24.9 kg/m(2), n = 174), the risk of the composite primary outcome was significantly lower in both the overweight (BMI 25–29.9 kg/m(2), n = 293; adjusted hazard ratio [HR] 0.50, 95 % CI 0.33-0.75) and obese class I/II groups (BMI 30–39.9 kg/m(2), n = 288; HR 0.62, 95 % CI 0.41-0.93), but not in the obese class III group (BMI ≥40 kg/m(2), n = 72; HR 0.94, 95 % CI 0.52-1.69). All-cause mortality was also lower in the overweight group (HR 0.50, 95 % CI 0.30-0.83). WC and ConI were not associated with either the composite primary outcome or mortality. CONCLUSION: BMI in the overweight range is associated with reduced risks of kidney disease progression and all-cause mortality in stage 3–4 CKD. WC and ConI were not independent predictors of these outcomes in this population. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12882-016-0290-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4939033
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49390332016-07-10 Association of anthropometric measures with kidney disease progression and mortality: a retrospective cohort study of pre-dialysis chronic kidney disease patients referred to a specialist renal service Davis, Emma Campbell, Katrina Gobe, Glenda Hawley, Carmel Isbel, Nicole Johnson, David W. BMC Nephrol Research Article BACKGROUND: Although elevated body mass index (BMI) is a predictor of better clinical outcomes in dialysis patients, the evidence in pre-dialysis chronic kidney disease (CKD) is conflicting. Clinical measures of central obesity may be better prognostic indicators, although investigation has been limited. The aim of this study was to assess the predictive value of anthropometric measures for kidney failure progression and mortality in stage 3–4 CKD. METHODS: The study included newly referred stage 3–4 CKD patients at a single centre between 1/1/2008 and 31/12/2010. The associations between clinical measures of obesity (BMI, waist circumference [WC] and conicity index [ConI]) and time to a composite primary outcome of doubling of serum creatinine, commencement of renal replacement therapy or mortality were evaluated using the Kaplan-Meier method and multivariable Cox regression models. RESULTS: Over a median follow-up period of 3.3 years, 229 (25.4 %) patients of a total population of 903 experienced the composite primary renal outcome. When compared to normal BMI (18.5-24.9 kg/m(2), n = 174), the risk of the composite primary outcome was significantly lower in both the overweight (BMI 25–29.9 kg/m(2), n = 293; adjusted hazard ratio [HR] 0.50, 95 % CI 0.33-0.75) and obese class I/II groups (BMI 30–39.9 kg/m(2), n = 288; HR 0.62, 95 % CI 0.41-0.93), but not in the obese class III group (BMI ≥40 kg/m(2), n = 72; HR 0.94, 95 % CI 0.52-1.69). All-cause mortality was also lower in the overweight group (HR 0.50, 95 % CI 0.30-0.83). WC and ConI were not associated with either the composite primary outcome or mortality. CONCLUSION: BMI in the overweight range is associated with reduced risks of kidney disease progression and all-cause mortality in stage 3–4 CKD. WC and ConI were not independent predictors of these outcomes in this population. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12882-016-0290-y) contains supplementary material, which is available to authorized users. BioMed Central 2016-07-08 /pmc/articles/PMC4939033/ /pubmed/27391644 http://dx.doi.org/10.1186/s12882-016-0290-y Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Davis, Emma
Campbell, Katrina
Gobe, Glenda
Hawley, Carmel
Isbel, Nicole
Johnson, David W.
Association of anthropometric measures with kidney disease progression and mortality: a retrospective cohort study of pre-dialysis chronic kidney disease patients referred to a specialist renal service
title Association of anthropometric measures with kidney disease progression and mortality: a retrospective cohort study of pre-dialysis chronic kidney disease patients referred to a specialist renal service
title_full Association of anthropometric measures with kidney disease progression and mortality: a retrospective cohort study of pre-dialysis chronic kidney disease patients referred to a specialist renal service
title_fullStr Association of anthropometric measures with kidney disease progression and mortality: a retrospective cohort study of pre-dialysis chronic kidney disease patients referred to a specialist renal service
title_full_unstemmed Association of anthropometric measures with kidney disease progression and mortality: a retrospective cohort study of pre-dialysis chronic kidney disease patients referred to a specialist renal service
title_short Association of anthropometric measures with kidney disease progression and mortality: a retrospective cohort study of pre-dialysis chronic kidney disease patients referred to a specialist renal service
title_sort association of anthropometric measures with kidney disease progression and mortality: a retrospective cohort study of pre-dialysis chronic kidney disease patients referred to a specialist renal service
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939033/
https://www.ncbi.nlm.nih.gov/pubmed/27391644
http://dx.doi.org/10.1186/s12882-016-0290-y
work_keys_str_mv AT davisemma associationofanthropometricmeasureswithkidneydiseaseprogressionandmortalityaretrospectivecohortstudyofpredialysischronickidneydiseasepatientsreferredtoaspecialistrenalservice
AT campbellkatrina associationofanthropometricmeasureswithkidneydiseaseprogressionandmortalityaretrospectivecohortstudyofpredialysischronickidneydiseasepatientsreferredtoaspecialistrenalservice
AT gobeglenda associationofanthropometricmeasureswithkidneydiseaseprogressionandmortalityaretrospectivecohortstudyofpredialysischronickidneydiseasepatientsreferredtoaspecialistrenalservice
AT hawleycarmel associationofanthropometricmeasureswithkidneydiseaseprogressionandmortalityaretrospectivecohortstudyofpredialysischronickidneydiseasepatientsreferredtoaspecialistrenalservice
AT isbelnicole associationofanthropometricmeasureswithkidneydiseaseprogressionandmortalityaretrospectivecohortstudyofpredialysischronickidneydiseasepatientsreferredtoaspecialistrenalservice
AT johnsondavidw associationofanthropometricmeasureswithkidneydiseaseprogressionandmortalityaretrospectivecohortstudyofpredialysischronickidneydiseasepatientsreferredtoaspecialistrenalservice